JP2006306885A5 - - Google Patents

Download PDF

Info

Publication number
JP2006306885A5
JP2006306885A5 JP2006175983A JP2006175983A JP2006306885A5 JP 2006306885 A5 JP2006306885 A5 JP 2006306885A5 JP 2006175983 A JP2006175983 A JP 2006175983A JP 2006175983 A JP2006175983 A JP 2006175983A JP 2006306885 A5 JP2006306885 A5 JP 2006306885A5
Authority
JP
Japan
Prior art keywords
amino
fluoro
ethyl
hydroxypropyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006175983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006306885A (ja
Filing date
Publication date
Priority claimed from SE9904508A external-priority patent/SE9904508D0/xx
Priority claimed from SE0003640A external-priority patent/SE0003640D0/xx
Application filed filed Critical
Publication of JP2006306885A publication Critical patent/JP2006306885A/ja
Publication of JP2006306885A5 publication Critical patent/JP2006306885A5/ja
Pending legal-status Critical Current

Links

JP2006175983A 1999-12-09 2006-06-27 新規なアミノプロピルホスフィン酸 Pending JP2006306885A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904508A SE9904508D0 (sv) 1999-12-09 1999-12-09 New compounds
SE0003640A SE0003640D0 (sv) 2000-10-09 2000-10-09 New compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001543550A Division JP3914435B2 (ja) 1999-12-09 2000-12-04 新規なアミノプロピルホスフィン酸

Publications (2)

Publication Number Publication Date
JP2006306885A JP2006306885A (ja) 2006-11-09
JP2006306885A5 true JP2006306885A5 (https=) 2008-01-17

Family

ID=26655259

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001543550A Expired - Fee Related JP3914435B2 (ja) 1999-12-09 2000-12-04 新規なアミノプロピルホスフィン酸
JP2006175983A Pending JP2006306885A (ja) 1999-12-09 2006-06-27 新規なアミノプロピルホスフィン酸

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001543550A Expired - Fee Related JP3914435B2 (ja) 1999-12-09 2000-12-04 新規なアミノプロピルホスフィン酸

Country Status (33)

Country Link
US (5) US6576626B2 (https=)
EP (2) EP1240172B1 (https=)
JP (2) JP3914435B2 (https=)
KR (1) KR100689144B1 (https=)
CN (1) CN1198832C (https=)
AR (1) AR030541A1 (https=)
AT (1) ATE282043T1 (https=)
AU (1) AU780459B2 (https=)
BR (1) BR0016253A (https=)
CA (1) CA2397583C (https=)
CZ (1) CZ20021983A3 (https=)
DE (1) DE60015796T2 (https=)
DK (1) DK1240172T3 (https=)
EE (1) EE05067B1 (https=)
ES (1) ES2230174T3 (https=)
HK (1) HK1048321B (https=)
HU (1) HUP0300301A3 (https=)
IL (2) IL149840A0 (https=)
IS (1) IS2231B (https=)
MX (1) MXPA02005536A (https=)
MY (1) MY125414A (https=)
NO (1) NO329595B1 (https=)
NZ (1) NZ519376A (https=)
PL (1) PL201789B1 (https=)
PT (1) PT1240172E (https=)
RU (1) RU2260595C2 (https=)
SE (1) SE9904508D0 (https=)
SI (1) SI1240172T1 (https=)
SK (1) SK286904B6 (https=)
TW (1) TWI228510B (https=)
UA (1) UA71649C2 (https=)
WO (1) WO2001042252A1 (https=)
ZA (1) ZA200204127B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
JP2004521898A (ja) * 2001-02-05 2004-07-22 カム、マイケル・アルバート 食道運動性疾患及び胃食道逆流性疾病の治療方法
AR033779A1 (es) * 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
WO2006050471A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
JP2009521428A (ja) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ 胃腸疾患治療用のイミダゾール誘導体
CA2632021A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Gaba-b receptor modulators
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
ES2373255T3 (es) 2007-05-04 2012-02-01 Astrazeneca Ab Proceso para s�?ntesis de �?cidos alquilfosf�?nicos mediante iniciación de una amina y un aminóxido.
EP2217245A4 (en) * 2007-07-25 2011-01-12 Astrazeneca Ab USE OF (3-AMINO-2-FLUOROPROPYL) -PHOSPHIC ACID FOR THE TREATMENT OF NERD
WO2009082345A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2009082344A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
WO2009082348A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
WO2009145716A1 (en) * 2008-05-28 2009-12-03 Astrazeneca Ab New pharmaceutical formulation useful in gerd therapy
WO2010051883A1 (de) 2008-11-05 2010-05-14 Clariant International Ltd Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung
DE102008056341A1 (de) 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
EP2352740B1 (de) 2008-11-07 2014-09-24 Clariant Finance (BVI) Limited Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung
EP2367835B1 (de) 2008-11-11 2013-12-11 Clariant Finance (BVI) Limited Verfahren zur herstellung von mono-allylfunktionalisierten dialkylphosphinsäuren, deren salze und ester mit allylischen verbindungen und ihre verwendung
DE102008060035A1 (de) * 2008-12-02 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de) 2008-12-04 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
DE102008063627A1 (de) * 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
DE102008063668A1 (de) 2008-12-18 2010-07-01 Clariant International Limited Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
KR101697948B1 (ko) 2008-12-18 2017-01-19 클라리언트 파이넌스 (비브이아이)리미티드 아세틸렌을 사용하는 에틸렌디알킬포스핀산, 에틸렌디알킬포스핀산 에스테르 및 에틸렌디알킬포스핀산 염의 제조방법 및 이의 용도
DE102008063642A1 (de) 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
DE102008064003A1 (de) 2008-12-19 2010-06-24 Clariant International Limited Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en) 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
EP0250572A1 (en) 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
US4740332A (en) * 1986-05-12 1988-04-26 E. R. Squibb & Sons, Inc. Process for preparing phosphonous acids
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5567840A (en) 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5281747A (en) 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5006560A (en) 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
FR2663934B1 (fr) 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
GB9125615D0 (en) * 1991-12-02 1992-01-29 Wyeth John & Brother Ltd Amines
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
FR2722192A1 (fr) 1994-07-06 1996-01-12 Adir Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en) 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds

Similar Documents

Publication Publication Date Title
JP2006306885A5 (https=)
JP2012508249A5 (https=)
JP2005533835A5 (https=)
CA2397583A1 (en) New aminopropylphosphinic acids
DE15177166T1 (de) S1p-rezeptormodulatoren für die behandlung von multipler sklerose
RU2015111229A (ru) Кристаллические формы гидрохлорида финголимода
JP2010138190A5 (https=)
JP2010095546A5 (https=)
JP2009537550A5 (https=)
JP2004529125A5 (https=)
JP2014500861A5 (https=)
CZ298197A3 (cs) Reverzibilní inhibitory proteas
JP2011518202A5 (https=)
JP2019501130A5 (https=)
JP2012503008A5 (https=)
RU2005100836A (ru) Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний
JP2002543202A5 (https=)
JP2014528464A5 (https=)
JP2012532883A5 (https=)
JP2003516346A5 (https=)
JP2006516280A5 (https=)
JP2017512211A5 (https=)
JP2017518363A5 (https=)
JP2021534160A5 (https=)
JP2019519593A5 (https=)